Franklin Joseph B, Marra Caroline, Abebe Kaleab Z, Butte Atul J, Cook Deborah J, Esserman Laura, Fleisher Lee A, Grossman Cynthia I, Kass Nancy E, Krumholz Harlan M, Rowan Kathy, Abernethy Amy P
Verily Life Sciences, South San Francisco, California.
Center for Biostatistics & Qualitative Methodology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
JAMA. 2024 Aug 5. doi: 10.1001/jama.2024.0268.
The ways in which we access, acquire, and use data in clinical trials have evolved very little over time, resulting in a fragmented and inefficient system that limits the amount and quality of evidence that can be generated.
Clinical trial design has advanced steadily over several decades. Yet the infrastructure for clinical trial data collection remains expensive and labor intensive and limits the amount of evidence that can be collected to inform whether and how interventions work for different patient populations. Meanwhile, there is increasing demand for evidence from randomized clinical trials to inform regulatory decisions, payment decisions, and clinical care. Although substantial public and industry investment in advancing electronic health record interoperability, data standardization, and the technology systems used for data capture have resulted in significant progress on various aspects of data generation, there is now a need to combine the results of these efforts and apply them more directly to the clinical trial data infrastructure.
We describe a vision for a modernized infrastructure that is centered around 2 related concepts. First, allowing the collection and rigorous evaluation of multiple data sources and types and, second, enabling the possibility to reuse health data for multiple purposes. We address the need for multidisciplinary collaboration and suggest ways to measure progress toward this goal.
随着时间的推移,我们在临床试验中获取、收集和使用数据的方式几乎没有什么变化,导致系统分散且效率低下,限制了可产生的证据数量和质量。
几十年来,临床试验设计一直在稳步推进。然而,临床试验数据收集的基础设施仍然昂贵且劳动密集,限制了为了解干预措施对不同患者群体是否有效以及如何有效而可收集的证据数量。与此同时,对随机临床试验证据以用于监管决策、支付决策和临床护理的需求日益增加。尽管公共和行业在推进电子健康记录互操作性、数据标准化以及用于数据捕获的技术系统方面投入了大量资金,在数据生成的各个方面都取得了重大进展,但现在需要将这些努力的成果结合起来,并更直接地应用于临床试验数据基础设施。
我们描述了一种围绕两个相关概念构建的现代化基础设施愿景。首先,允许对多种数据源和类型进行收集和严格评估,其次,使健康数据能够用于多种目的的再利用成为可能。我们阐述了多学科协作的必要性,并提出了衡量朝着这一目标取得进展的方法。